Lexus India Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U51909DL1992PLC048996 Incorporated 01 June 1992 ROC Delhi HQ New Delhi, Delhi, India
Under Insolvency Public Limited Company pharma
Data last updated
Revenue · FY 2024
₹5.32 Cr
▲ 99% YoY
Net loss · FY 2024
₹77.96 Lakh
Net margin -14.7%
EBITDA · FY 2024
-₹60.81 Lakh
EBITDA margin -11.4%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹3.23 Cr
Issued & subscribed
Open charges
₹6.6 Cr
Secured borrowings
Company age
34 yrs
Est. 1992
Directors on board
5
As per MCA filings

About Lexus India Limited

Data last updated:

Lexus India Limited is a public limited company based in New Delhi, Delhi, India. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 June 1992.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL1992PLC048996. Its GSTIN is 05AAACL6145N1ZC (Uttarakhand).

The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.23 Cr. It is led by directors including Pramod Kumar Saraf (Managing Director) and Sandeep Kumar Kandoi.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H – 25 First Floor Kailash Colony, New Delhi, Delhi, India – 110048.

As per the financials filed for FY 2024, the company reported a revenue of ₹5.32 Cr, a growth of 99% compared to the previous year. For the same year it recorded a net loss of ₹77.96 Lakh (net margin -14.7%) and EBITDA of -₹60.81 Lakh (EBITDA margin -11.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 44% over five years.

The company is associated with 1 brand: Lexus India. As per MCA filings, the company has open charges of ₹6.6 Cr on record. Court records list 55 cases involving the company, including 2 filed by the company and 52 filed against it; 3 cases are pending.

Company Details of Lexus India Limited
CIN U51909DL1992PLC048996
Registration Number 048996
Incorporation Date 01 June 1992
ROC Delhi
Listing Status Unlisted
Company Status Under CIRP
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    H – 25 First Floor Kailash Colony, New Delhi, Delhi, India – 110048
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Lexus India Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Lexus India Limited report

Financials, compliance, directors, charges, ownership and filings for Lexus India Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Lexus India Limited

The main business activity of Lexus India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Lexus India Limited FY 2024 filings available

Lexus India Limited reported revenue of ₹5.32 Cr (up 99% YoY) for FY 2024.

Revenue · FY 2024
₹5.32 Cr ▲ 99%
Net loss · FY 2024
₹77.96 Lakh margin -14.7%
EBITDA · FY 2024
-₹60.81 Lakh margin -11.4%

Compounded Annual Growth Rate (CAGR) of Lexus India Limited

Revenue CAGR growth
1 year
▲ 99%
3 years · compounded
▲ 2%
5 years · compounded
▲ 44%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▼ 177%
5 years · compounded
▼ 15%

Revenue has grown at a compounded annual rate (CAGR) of 44% over five years, including 99% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Lexus India Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue₹5.32 Cr••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹60.81 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹77.96 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Lexus India Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-11.4%••••••••••••••••
Net Profit Margin-14.7%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lexus India are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Lexus India Limited

Lexus India Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Brochem Healthcare Private Limited₹5.34 Cr (FY 2023)••••••••19.0%••••Navi Mumbai, Maharashtra, India
Sahyog Creations Private Limited₹5.34 Cr (FY 2024)••••••••••••Solapur, Maharashtra, India
Wych Elm Laboratories Limited₹5.33 Cr (FY 2025)••••••••20.0%••••Kolkata, West Bengal, India
A R K Health Care Pvt Ltd₹5.32 Cr (FY 2024)••••••••-34.0%••••Manimajra, Chandigarh, India
Harihar Pharmaceuticals Private Limited₹5.32 Cr (FY 2025)••••••••7.0%••••Bolangir, Odisha, India
Lexus India Limited this company₹5.32 Cr (FY 2024)••••••••99.0%••••New Delhi, Delhi, India
Meticulous Pharmaceticals Private Limited₹5.31 Cr (FY 2025)••••••••36.0%••••Uttar Pradesh, India
Swastik Formulations Private Limited₹5.3 Cr (FY 2025)••••••••13.0%••••Uttar Pradesh, India
Nupur Pharma Private Limited₹5.3 Cr (FY 2025)••••••••-6.0%••••Delhi, India
Edence Life Sciences Private Limited₹5.29 Cr (FY 2024)••••••••17.0%••••Mumbai, Maharashtra, India
Synnova Intermediates Private Limited₹5.29 Cr (FY 2025)••••••••18325.0%••••Mumbai, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Lexus India by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Lexus India Limited

Lexus India Limited is audited by SANJAY REMMY & CO for the financial year 2024.

NameStatusAppointment DateCessation Date
SANJAY REMMY & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Lexus India Limited

Lexus India has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Pramod Kumar SarafManaging Director30 Nov 200025 Years 10 MonthsAs last reported
Sandeep Kumar KandoiDirector19 Apr 200719 Years 5 MonthsAs last reported
Shubham SarafDirector30 Apr 20188 Years 5 MonthsAs last reported
Satish AgarwalDirector01 Jun 199234 Years 4 MonthsAs last reported
Kusum SarafDirector15 May 200224 Years 4 MonthsAs last reported

Ownership and Shareholding of Lexus India Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Lexus India Limited

Open charges
₹6.6 Cr
Satisfied charges
None
Breakdown by lending institutions
Small Industries Development Bank of India₹4.60 Cr
Bank of India₹2.00 Cr
Latest charge details
DateLenderAmountStatus
13 Oct 2007Bank of India₹2 CrOpen
11 Nov 2006Small Industries Development Bank of India₹4.6 CrOpen

Total charge records: 2 View all charges

Associated Brands with Lexus India Limited

Lexus India operates one associated brand: Lexus India. Each brand links to its own profile.

BrandDescriptionWebsite
Luxury vehicles are manufactured and distributed by Lexus globally.lexusindia.co.in

Employees and EPFO Compliance at Lexus India Limited

Employment history and EPFO contributions of people linked to Lexus India.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Lexus India Limited

Lexus India Limited has 10 board changes on record since 1992: 5 appointments and 5 cessations. The latest: Shubham Saraf ceased to be Additional Director on 29 Sep 2018.

AGM
Lexus India Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Lexus India Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Shubham Saraf ceased to be Additional Director.
Ceased
Satish Agarwal ceased to be Director.
Appointed
Shubham Saraf was appointed as Director.
Ceased
Sandeep Kumar Kandoi ceased to be Director.
Charges
A charge with Bank Of India of Rs. 2.00 Cr registered on 13 Oct 2007 with Charge ID 10076748 was modified on 06 Apr 2010.
Ceased
Vinay Agarwal ceased to be Director.
Charges
A charge with Bank Of India amounted to Rs. 2.00 Cr with Charge ID 10076748 was registered on 13 Oct 2007.
Ceased
Rakesh Prakash Kaushik ceased to be Director.
Appointed
Sandeep Kumar Kandoi was appointed as Director.
Charges
A charge with Small Industries Development Bank Of India amounted to Rs. 4.60 Cr with Charge ID 90333931 was registered on 11 Nov 2006.

4 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Lexus India Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Lexus India Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Lexus India Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Lexus India Limited

Lexus India has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
05AAACL6145N1ZCUttarakhandActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Lexus India Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lexus India Limited

Lexus India is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.

Lexus India is a company under insolvency, formerly operating as a public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 June 1992 and is registered under CIN U51909DL1992PLC048996. Caution is advised - the company may not have the legal capacity to fulfil new agreements.

Lexus India reported revenue of ₹5.32 Cr for FY 2024 (up 99% YoY).

Lexus India has 5 current directors:

Lexus India reported a net loss of ₹77.96 Lakh (net margin -14.7%) and EBITDA of -₹60.81 Lakh (EBITDA margin -11.4%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Lexus India is 2% over three years and 44% over five years. In the latest year (FY 2024) revenue rose 99%. CAGR is the steady yearly rate that links the first and the last year.

The CIN (Corporate Identification Number) of Lexus India is U51909DL1992PLC048996. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Lexus India has open charges of ₹6.6 Cr and no satisfied charges on record as per latest MCA filings.

Lexus India has 55 court cases on record: 2 filed by the company and 52 filed against it. 3 are pending. Most are in the district courts.

Lexus India was incorporated on 01 June 1992. It is registered with the Registrar of Companies, Delhi.

The peers of Lexus India by revenue are Brochem Healthcare Private Limited, Sahyog Creations Private Limited, Wych Elm Laboratories Limited, A R K Health Care Pvt Ltd, Harihar Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available